BeOne Medicines Ltd. R&D Expense 2014-2026 | ONC
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is BeOne Medicines Ltd.'s current r&d expense?
BeOne Medicines Ltd. (ONC) annual r&d expense for 2025 was $2.15B, a 9.86% increase from 2024. BeOne Medicines Ltd. r&d expense for the quarter ending March 31, 2026 was $541.2M.
What was BeOne Medicines Ltd.'s r&d expense in 2024?
BeOne Medicines Ltd. annual r&d expense for 2024 was $1.95B, a 9.82% increase from 2023.
What was BeOne Medicines Ltd.'s r&d expense in 2023?
BeOne Medicines Ltd. annual r&d expense for 2023 was $1.78B, a 8.42% increase from 2022.
What is BeOne Medicines Ltd.'s 5-year r&d expense CAGR?
BeOne Medicines Ltd. r&d expense grew at a compound annual growth rate (CAGR) of 10.63% from FY2020 to FY2025, going from $1.29B to $2.15B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.6%
FY2020
$1.29B
→
FY2025
$2.15B
141516171819202122232425
5 years selected
R&D Expense History
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →